awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28534819-DC820606-50AB-4A84-9518-6C0BB2624C4B
Q28534819-DC820606-50AB-4A84-9518-6C0BB2624C4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534819-DC820606-50AB-4A84-9518-6C0BB2624C4B
Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer
P2860
Q28534819-DC820606-50AB-4A84-9518-6C0BB2624C4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534819-DC820606-50AB-4A84-9518-6C0BB2624C4B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
127065a8fddeecf3dccb22fb19258607af6b4d33
P2860
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.